(See A.E. Dart et al., “The drebrin/EB3 pathway drives invasive activity in prostate cancer,” Oncogene, doi:10.1038/onc.2017.45, 2017.)
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!